Greenwood Capital Associates sold 21.9% of its Johnson & Johnson holdings in Q1, reducing their stake by over 15,000 shares.

Berkshire Hathaway’s energy portfolio is a tale of two strategies—one bold, one beautifully boring—and the latter is winning ...

Oracle just dropped its fiscal 2025 curtain and is already hyping fiscal 2026 with cloud-powered ambition. Morgan Stanley ...

AbbVie’s price target got a fresh boost as Citigroup raised it to $205, joining a chorus of analysts expressing optimism.

Costco continues to defy retail gravity with a rock-solid membership model, efficient operations, and e-commerce hustle. The ...

Merck shares fell 1.27%, lagging behind the S&P 500’s smaller dip of 0.27%. This decline comes despite Merck’s prior ...

Coca-Cola Europacific Partners just scooped up 49,789 of its own shares as part of a sizzling buyback move. The company ...

Salesforce just turned some analyst heads with a forecasted earnings-per-share of $8.55 for FY2026, outpacing consensus by ...

AMD and Cisco are diving headfirst into the Saudi cloud, joining forces with HUMAIN to develop AI infrastructure across the ...

Griffith & Werner Inc. increased its stake in Bank of America by 13.4%, acquiring 13,497 more shares to reach 114,556 in ...

Thermo Fisher Scientific’s stock saw a modest rise of 0.22% after a rollercoaster trading session that started hot and ended ...

Adobe is gearing up to report its Q2 Fiscal 2025 earnings, with analysts expecting EPS of $4.97 and revenue of $5.80 billion.